Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
89 hedge funds and large institutions have $83.6M invested in Gritstone bio, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 9 closing their positions.
78% more call options, than puts
Call options by funds: $226K | Put options by funds: $127K
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% more funds holding
Funds holding: 88 → 89 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
16% less capital invested
Capital invested by funds: $99.5M → $83.6M (-$15.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$2.93M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$277K |
| 3 |
MCM
Moore Capital Management
New York
|
+$178K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$172K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.93M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$1.72M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$1.3M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$676K |
| 5 |
HFRG
Houlihan Financial Resource Group
Ashburn,
Virginia
|
-$604K |
GRTS Hedge Fund Activity: Q3 2023 in Review
89 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2023, worth a combined $83.6M — down 16% from $99.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GRTS positions and 9 closed out — a net gain of 1 holder — while 26 added to existing stakes and 29 trimmed.
The largest buyer was Redmile Group, adding an estimated $2.93M. The largest seller was Point72 Asset Management, cutting an estimated $2.93M.
- 89 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2023, up from 88 in Q2 2023.
- Funds reported $83.6M of Gritstone bio, Inc. Common Stock stock for Q3 2023, down 16% quarter-over-quarter.
- 10 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2023 and 9 closed out, a net change of +1 holder.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2023 was Redmile Group, an estimated $2.93M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2023 was Point72 Asset Management, an estimated $2.93M sold.
Based on aggregated 13F filings for Q3 2023.